Genetic Predictors of Lithium Response
Lithium remains a first-line pharmacological treatment of bipolar disorder (BD). However, treatment response is heterogeneous, with several lines of evidence implicating genetic factors. Unfortunately, neither hypothesis-driven approaches nor initial genome-wide association studies (GWAS) were succe...
Saved in:
| Main Author: | U. Heilbronner |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Federal State Budget Scientific Institution National Medical Research Center for Psychiatry and Neurology n.a. V.M. Bekhterev Ministry of Health of the Russian Federation
2019-12-01
|
| Series: | Обозрение психиатрии и медицинской психологии имени В.М. Бехтерева |
| Subjects: | |
| Online Access: | https://www.bekhterevreview.com/jour/article/view/295 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The International Consortium of Lithium Genetics (ConLiGen): Achievements and Collaborations
by: U. Heilbronner
Published: (2019-12-01) -
Deciphering the epigenetic role of long non‐coding RNAs in mood disorders: Focus on human brain studies
by: Bhaskar Roy, et al.
Published: (2025-03-01) -
Evaluation of novel candidate variations and their interactions related to bipolar disorders: Analysis of GWAS data
by: Acikel C, et al.
Published: (2016-11-01) -
Human Blood-Derived lncRNAs in Autism Spectrum Disorder
by: Carmela Serpe, et al.
Published: (2025-06-01) -
Non-coding RNA-mediated regulation of seed endosperm development
by: Xinqi Wei, et al.
Published: (2025-08-01)